ES2149216T3 - Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos. - Google Patents
Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos.Info
- Publication number
- ES2149216T3 ES2149216T3 ES93923615T ES93923615T ES2149216T3 ES 2149216 T3 ES2149216 T3 ES 2149216T3 ES 93923615 T ES93923615 T ES 93923615T ES 93923615 T ES93923615 T ES 93923615T ES 2149216 T3 ES2149216 T3 ES 2149216T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- disorders
- cognoscitive
- pct
- piperazine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
DERIVADOS DE PIPERAZINA DE FORMULA (I) SON UTILES EN EL TRATAMIENTO DE TRASTORNOS COGNITIVOS. EN LA FORMULA (I) X ES UN GRUPO DE (IIA): - (CH 2 ) N CR 2 3 CONR 4 R 5 O (IIB): - A - NR 6 COR 7 EN EL QUE N, A, R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 Y R 7 TIENEN SIGNIFICADOS ESPECIFICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2149216T3 true ES2149216T3 (es) | 2000-11-01 |
Family
ID=10724559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93923615T Expired - Lifetime ES2149216T3 (es) | 1992-11-05 | 1993-10-25 | Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5827847A (es) |
EP (1) | EP0877612B1 (es) |
JP (1) | JP3238153B2 (es) |
AT (1) | ATE195422T1 (es) |
AU (1) | AU682155B2 (es) |
CA (1) | CA2148593C (es) |
DE (1) | DE69329252T2 (es) |
DK (1) | DK0877612T3 (es) |
ES (1) | ES2149216T3 (es) |
GB (1) | GB9223153D0 (es) |
GR (1) | GR3034400T3 (es) |
HU (1) | HUT72049A (es) |
LV (1) | LV12734B (es) |
MX (1) | MX9306879A (es) |
PT (1) | PT877612E (es) |
TW (1) | TW252043B (es) |
WO (1) | WO1994009780A1 (es) |
ZA (1) | ZA937827B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
GB2230781B (en) * | 1989-04-22 | 1993-04-28 | Wyeth John & Brother Ltd | Piperazine derivatives |
NZ233398A (en) * | 1989-04-22 | 1991-12-23 | American Home Prod | Aryl- or heteroaryl-substituted piperazine derivatives and pharmaceutical compositions |
EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
EP0510068B1 (en) * | 1990-01-11 | 1999-04-14 | PHARMACIA & UPJOHN COMPANY | NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 EP EP93923615A patent/EP0877612B1/en not_active Expired - Lifetime
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en active IP Right Grant
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GR3034400T3 (en) | 2000-12-29 |
CA2148593A1 (en) | 1994-05-11 |
US5827847A (en) | 1998-10-27 |
AU5342194A (en) | 1994-05-24 |
DE69329252T2 (de) | 2001-03-29 |
LV12734A (en) | 2001-10-20 |
LV12734B (en) | 2002-01-20 |
TW252043B (es) | 1995-07-21 |
JPH08502743A (ja) | 1996-03-26 |
HUT72049A (en) | 1996-03-28 |
JP3238153B2 (ja) | 2001-12-10 |
HU9501290D0 (en) | 1995-06-28 |
DE69329252D1 (de) | 2000-09-21 |
WO1994009780A1 (en) | 1994-05-11 |
DK0877612T3 (da) | 2000-10-09 |
ATE195422T1 (de) | 2000-09-15 |
MX9306879A (es) | 1995-01-31 |
EP0877612A1 (en) | 1998-11-18 |
GB9223153D0 (en) | 1992-12-16 |
PT877612E (pt) | 2000-11-30 |
ZA937827B (en) | 1995-04-21 |
CA2148593C (en) | 2005-12-06 |
EP0877612B1 (en) | 2000-08-16 |
AU682155B2 (en) | 1997-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL123142A0 (en) | The use of adamantan-derivatives for the treatment of the inner ear | |
ES2141174T3 (es) | 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina. | |
ATE120738T1 (de) | 2,4-diamino-pyrimidin-3-oxid-derivate und deren verwendung bei der behandlung und zur verhütung von haarfall. | |
DE69433984D1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
ES2134929T3 (es) | Derivados de pirrolo-piridina como ligandos para receptores de dopamina. | |
DE69424009D1 (de) | Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst | |
DK0572635T3 (da) | Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne | |
ES2123756T3 (es) | Derivados de piperazina. | |
ES2149216T3 (es) | Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos. | |
DE69414264D1 (de) | 1-arylcycloalkyl sulfide, sulfoxide und sulfone zur behandlung von depression, angst und morbus parkinson | |
PT1068184E (pt) | Derivados n-ariloxietilamina para o tratamento de depressao | |
HU9502067D0 (en) | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders | |
DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet | |
GB9304632D0 (en) | Amide derivatives | |
SE9603284D0 (sv) | New compounds | |
DE59309469D1 (de) | Triazolochinazoline zur behandlung zentralnervöser erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 877612 Country of ref document: ES |